Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CI 
Cigna Corp (CI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/17/2025: CI (1-star) is a SELL. SELL since 4 days. Profits (-8.32%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
25 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $375.34
1 Year Target Price $375.34
| 13 | Strong Buy |
| 6 | Buy |
| 6 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -5.76% | Avg. Invested days 37 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/17/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 81.70B USD | Price to earnings Ratio 17.06 | 1Y Target Price 375.34 |
Price to earnings Ratio 17.06 | 1Y Target Price 375.34 | ||
Volume (30-day avg) 25 | Beta 0.45 | 52 Weeks Range 259.50 - 365.71 | Updated Date 07/17/2025 |
52 Weeks Range 259.50 - 365.71 | Updated Date 07/17/2025 | ||
Dividends yield (FY) 1.83% | Basic EPS (TTM) 17.93 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.97% | Operating Margin (TTM) 3.64% |
Management Effectiveness
Return on Assets (TTM) 4.03% | Return on Equity (TTM) 13.21% |
Valuation
Trailing PE 17.06 | Forward PE 10.32 | Enterprise Value 103074235446 | Price to Sales(TTM) 0.32 |
Enterprise Value 103074235446 | Price to Sales(TTM) 0.32 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 267143008 | Shares Floating 265860313 |
Shares Outstanding 267143008 | Shares Floating 265860313 | ||
Percent Insiders 1.59 | Percent Institutions 92.01 |
Upturn AI SWOT
Cigna Corp
Company Overview
History and Background
Cigna Corp was formed in 1982 through the merger of INA Corporation and Connecticut General Corporation. INA was founded in 1792, making it one of the oldest insurance companies in the United States. The company has evolved from a traditional insurance provider to a global health service company.
Core Business Areas
- Evernorth: Evernorth, Cigna's health services segment, includes pharmacy benefits management (PBM), specialty pharmacy services, and care delivery and management solutions.
- Cigna Healthcare: Cigna Healthcare offers commercial health insurance, Medicare Advantage, Medicare Supplement, and individual & family plans, as well as international health insurance.
- Corporate and Other: Includes run-off reinsurance operations, as well as corporate operations and activities.
Leadership and Structure
David Cordani is the Chairman and CEO. The company is structured with various business segments, each led by a president who reports to the CEO. The corporate structure includes functional departments such as finance, legal, and human resources.
Top Products and Market Share
Key Offerings
- Market Share (%): 25
- Pharmacy Benefits Management (PBM): Through Evernorth, Cigna provides PBM services, managing prescription drug benefits for health plans and employers. Market share data for specific PBM services fluctuates, but Cigna is a major player. Competitors include CVS Caremark, UnitedHealth Group's OptumRx, and Express Scripts.
- Commercial Health Insurance: Cigna Healthcare provides medical, dental, and vision insurance plans to employers and individuals. Competitors include UnitedHealthcare, Anthem, Aetna (CVS Health), and Humana.
- Market Share (%): 10
- Market Share (%): 5
- Medicare Advantage: Cigna offers Medicare Advantage plans to seniors. Competitors include UnitedHealthcare, Humana, and CVS Health.
Market Dynamics
Industry Overview
The health insurance industry is characterized by increasing consolidation, regulatory changes (e.g., Affordable Care Act), rising healthcare costs, and a shift towards value-based care. Demand for specialized healthcare services and digital health solutions is increasing.
Positioning
Cigna is positioned as a global health service company that focuses on providing integrated health solutions and personalized care. Its strengths lie in its diversified business model, strong PBM capabilities, and international presence.
Total Addressable Market (TAM)
The US health insurance market is estimated to be worth over $1 trillion. Cigna captures a portion of this TAM through its various segments, with a focus on growth in pharmacy benefits and value-based care.
Upturn SWOT Analysis
Strengths
- Diversified business model
- Strong PBM capabilities (Evernorth)
- Global presence
- Focus on value-based care
- Strong financial performance
Weaknesses
- Exposure to regulatory changes
- Integration risks from acquisitions
- Competitive pressure in the health insurance market
- Dependence on large employer groups
Opportunities
- Expansion of Medicare Advantage offerings
- Growth in international markets
- Increased demand for telehealth and digital health solutions
- Strategic acquisitions and partnerships
- Further development of value-based care models
Threats
- Increasing healthcare costs
- Regulatory uncertainty
- Intense competition
- Cybersecurity risks
- Economic downturn
Competitors and Market Share
Key Competitors
- UNH
- ANTM
- HUM
- CVS
Competitive Landscape
Cigna's advantages include its strong PBM capabilities, global presence, and focus on value-based care. Disadvantages include exposure to regulatory changes and competitive pressure in the health insurance market.
Major Acquisitions
Express Scripts
- Year: 2018
- Acquisition Price (USD millions): 67000
- Strategic Rationale: Acquisition of Express Scripts to create an integrated health services company, combining pharmacy benefits management with health insurance capabilities.
MDLive
- Year: 2021
- Acquisition Price (USD millions): 0
- Strategic Rationale: Enhance telehealth offerings to increase access to affordable, convenient care.
Growth Trajectory and Initiatives
Historical Growth: Cigna has experienced consistent revenue growth driven by its diversified business model and strategic acquisitions.
Future Projections: Analysts project continued revenue growth, driven by expansion in Medicare Advantage, pharmacy benefits, and international markets. EPS is expected to grow at a moderate pace.
Recent Initiatives: Recent initiatives include expanding telehealth offerings, investing in digital health solutions, and focusing on value-based care arrangements.
Summary
Cigna is a strong global health service company with a diversified business model. Its PBM segment, Evernorth, and growing Medicare Advantage business drive revenue. Regulatory changes and increasing healthcare costs pose challenges. Strategic initiatives in telehealth and value-based care position Cigna for future growth. Cigna must manage debt levels from recent acquisition but is performing well.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Presentations
- Earnings Call Transcripts
- Industry Reports
- Market Data Providers
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cigna Corp
Exchange NYSE | Headquaters Bloomfield, CT, United States | ||
IPO Launch date 1982-03-31 | CEO & Chair of the Board Mr. David Michael Cordani | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 71295 | Website https://www.cigna.com |
Full time employees 71295 | Website https://www.cigna.com | ||
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.